Hyzaar/Hyzaar Plus/Hyzaar Forte Patient Counseling Information

Advise the patient to read Patient Information.
Pregnancy: Advise female patients of childbearing age about the consequences of exposure to HYZAAR, HYZAAR PLUS, or HYZAAR FORTE during pregnancy. Discuss treatment options with women planning to become pregnant. Tell patients to report pregnancies to their physicians as soon as possible [see Fetal Toxicity under Precautions and Pregnancy under Use in Pregnancy & Lactation].
Symptomatic Hypotension: Advise patients that lightheadedness can occur, especially during the first days of therapy, and to report this symptom to a healthcare provider. Inform patients that dehydration from inadequate fluid intake, excessive perspiration, vomiting, or diarrhea may lead to an excessive fall in blood pressure. If syncope occurs advise patients to contact their healthcare provider [see Hypotension in Volume- or Salt-Depleted Patients under Precautions].
Potassium Supplements: Advise patients not to use potassium supplements or salt substitutes containing potassium without consulting their healthcare provider [see Agents Increasing Serum Potassium under Interactions].
Choroidal Effusion, Acute Myopia and Secondary Angle-Closure Glaucoma: Advise patients to discontinue HYZAAR, HYZAAR PLUS, or HYZAAR FORTE and seek immediate medical attention if they experience symptoms of choroidal effusion or acute myopia or secondary angle-closure glaucoma [see Choroidal Effusion, Acute Myopia and Secondary Angle-Closure Glaucoma under Precautions].
Non-melanoma Skin Cancer: Instruct patients taking hydrochlorothiazide to protect skin from the sun and undergo regular skin cancer screening.